AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Stethoscope, glasses, pen and paper

2027 proposed Medicare fee schedule: What physicians need to know

| 11 Min Read
Healthcare worker places bandage on smiling patient

Doctors united on respiratory virus vaccine recommendations

| 10 Min Read
Couple looks at a tablet

Bill would put an end to yearly patches on Medicare physician pay

| 7 Min Read
Smiling patient listens to doctor

Better handoffs help home care cut hospital readmissions

| 6 Min Read